Optimization of metabolic stability as a goal of modern drug design (Q34386836)

1 August 2017

1 reference

title

Optimization of metabolic stability as a goal of modern drug design (English)

1 reference

1 August 2017

Thompson TN

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Medicinal Research Reviews

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

412-449

1 reference

Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives

1 August 2017

cites work

1 reference

The use of in vitro metabolism studies in the understanding of new drugs

21 January 2018

1 reference

Design of drugs through a consideration of drug metabolism and pharmacokinetics

21 January 2018

1 reference

Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics

21 January 2018

1 reference

Early ADME in support of drug discovery: the role of metabolic stability studies

21 January 2018

1 reference

High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery

21 January 2018

1 reference

Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)

21 January 2018

1 reference

Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective

21 January 2018

1 reference

High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds

21 January 2018

1 reference

The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies

21 January 2018

1 reference

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

21 January 2018

1 reference

Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport

21 January 2018

1 reference

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data

21 January 2018

1 reference

Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations

21 January 2018

1 reference

Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes

21 January 2018

1 reference

Synthetic strategies to lower affinity for CYP2D6.

21 January 2018

1 reference

Hydrolysis of carbonates, thiocarbonates, carbamates, and carboxylic esters of alpha-naphthol, beta-naphthol, and p-nitrophenol by human, rat, and mouse liver carboxylesterases

21 January 2018

1 reference

Application of oral bioavailability surrogates in the design of orally active inhibitors of rhinovirus replication

21 January 2018

1 reference

Synthesis, antiviral activity, and biological properties of vinylacetylene analogs of enviroxime

21 January 2018

1 reference

Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy

21 January 2018

1 reference

Synthesis and bioactivity of novel bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships and increased metabolic stability of novel substituted pyridine analogs

21 January 2018

1 reference

Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines

21 January 2018

1 reference

Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties

21 January 2018

1 reference

Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability

21 January 2018

1 reference

Isoindol-1-one Analogues of 4-(2‘-methoxyphenyl)-1-[2‘-[N-(2‘‘-pyridyl)-p-iodobenzamido]ethyl]piperazine (p-MPPI) as 5-HT1A Receptor Ligands

21 January 2018

1 reference

High-throughput high-performance liquid chromatography/mass spectrometry for modern drug discovery

21 January 2018

1 reference

Quantitative structure-activity relationships of cytochrome P-450.

21 January 2018

1 reference

Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles

21 January 2018

1 reference

Computational methods for the prediction of 'drug-likeness'

21 January 2018

1 reference

QSAR model for drug human oral bioavailability.

21 January 2018

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver Slices

21 January 2018

1 reference

Advances in drug metabolism screening

21 January 2018

1 reference

Development of an automated mass spectrometry system for the quantitative analysis of liver microsomal incubation samples: a tool for rapid screening of new compounds for metabolic stability

21 January 2018

1 reference

Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6

21 January 2018

1 reference

A novel approach to predicting P450 mediated drug metabolism. CYP2D6 catalyzed N-dealkylation reactions and qualitative metabolite predictions using a combined protein and pharmacophore model for CYP2D6

21 January 2018

1 reference

Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4

21 January 2018

1 reference

Discovery of bioavailable inhibitors of secretory phospholipase A2

21 January 2018

1 reference

Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability

21 January 2018

1 reference

In vitro stability and intestinal absorption characteristics of hexapeptide endothelin receptor antagonists

21 January 2018

1 reference

Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors

21 January 2018

1 reference

On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism

21 January 2018

1 reference

Use and value of metabolism databases

21 January 2018

1 reference

Predicting the regioselectivity and stereoselectivity of cytochrome P450-mediated reactions: structural models for bioactivation reactions.

21 January 2018

1 reference

Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.1017

1 reference

release_yts5joxaujddphdodgcbq5mjd4

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yts5joxaujddphdodgcbq5mjd4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference